Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Abbott Laboratories    ABT   US0028241000

End-of-day quote. End-of-day quote Swiss Exchange - 05/27
45.6 CHF   +0.33%
05/18DJCredits & Debits
05/14 ABBOTT LABORATO : Enters into Agreement with GE Healthcare
05/13 ASTRAZENECA : Enters Companion Diagnostic Test Deal With Abbott
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Abbott Laboratories
Engages in the discovery, development, manufacture and sale of health care products

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products.

The company operates through four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products.

The Established Pharmaceutical Products segment includes branded generic pharmaceuticals manufactured, marketed and sold outside the United States and are generally sold directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its owned distribution centers and public warehouses, depending on the market served.

The Diagnostic Products segment includes diagnostic systems and tests manufactured, marketed, and sold worldwide to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate-care testing sites, and plasma protein therapeutic companies.

The segment's products are generally marketed and sold directly from Abbott-owned distribution centers, public warehouses and third-party distributors.

The Nutritional Products segment includes pediatric and adult nutritional products manufactured, marketed, and sold worldwide.

Its products are generally marketed and sold directly to customers and to institutions, wholesalers, retailers, health care facilities, government agencies, and third-party distributors from owned distribution centers or third-party distributors.

The Vascular Products segment includes coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease manufactured, marketed and sold worldwide.

The segment's products are generally marketed and sold directly to hospitals from Abbott-owned distribution centers and public warehouses.

Abbott Laboratories was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Managers
NameAgeSinceTitle
Miles White601984Chairman & Chief Executive Officer
Thomas Freyman601979Chief Financial Officer & Executive Vice President
Preston T. Simons--Vice President-Information Technology
Roxanne S. Austin, CPA542000Independent Director
Jim Farrell722006Independent Director
Samuel C. Scott III, MBA692007Independent Director
Glenn Fletcher Tilton662007Independent Director
William A. Osborn, MBA672008Lead Independent Director
Robert J. Alpern, MD642008Independent Director
Edward Michael Liddy, MBA692010Independent Director
Shareholders
NameShares%
The Vanguard Group, Inc. 90,359,272 5.99%
SSgA Funds Management, Inc. 65,054,695 4.31%
BlackRock Fund Advisors 60,533,866 4.01%
Massachusetts Financial Services Co. 33,362,223 2.21%
Northern Trust Investments, Inc. 23,855,856 1.58%
Jennison Associates LLC 21,571,193 1.43%
PRIMECAP Management Co. 17,765,299 1.18%
State Farm Investment Management Corp. 15,198,300 1.01%
Morgan Stanley Smith Barney LLC 14,510,466 0.96%
T. Rowe Price Associates, Inc. 13,200,496 0.87%
Holdings
NameShares%Valuation
Mylan NV (MYL) 69,750,00014.3%5,040,135,000 USD
Abbott India Limited (ABBOTINDIA) 10,719,09750.4%665,051,474 USD
CFR Pharmaceuticals SA (CFR) 1,722,927,10120.3%583,072,990 USD
Abbott Laboratories Pakistan Limited 76,259,44977.9%416,233,986 USD
NeoGenomics, Inc. (NEO) 865,5581.44%3,920,978 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ACTAVIS PLC
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
CSL LIMITED
Sector Pharmaceuticals
Abbott Laboratories : Connections
Edgewater Growth Capital Partners
The Chicago Urban League
The American Institute of Certified Public Accountants
INROADS Chicago
Austin Investment Advisors
Abbott Laboratories Trading (Shanghai) Co. Ltd.
S&P Corporate Ratings Issuer Council
Chicago Botanic Garden
The Chicago Council on Global Affairs
The Culver Educational Foundation
The Field Museum of Natural History
The Big Shoulders Fund
Waud Capital Partners LLC
The Chicago Community Trust
Chicago Sister Cities International Program, Inc.
The Commercial Club of Chicago
Chicago Symphony Orchestra Association
Northwestern Memorial HealthCare
Healthcare Leadership Council
Junior Achievement of Chicago
After School Matters, Inc.
Yale School of Medicine
Lyric Opera of Chicago
California Science Center
American Cancer Society, Inc.
California Society of Certified Public Accountants
Tricida, Inc.
The Museum of Science & Industry
US Foods, Inc.
Boys & Girls Clubs of America
ATD Corp.
United Way of Metropolitan Chicago, Inc.
Catalyst, Inc.
Company contact information
100 road Abbott Park
US-IL 60064-6400 Palatine, Illinois
États-Unis (les)

Phone : +1 (847)937 6100
Fax : +1
Internet : http://www.abbott.com
Markets and indexes
- NYSE
- Main Market
- SP100 / SP500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  US0028241000
- Bloomberg Code :  ABT:US
- Reuters Code :  ABT.N
- Datastream Code :  
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem